Get the Stockscreener App
9.99
2.67%
0.26
After Hours:
9.99
Personalis Inc stock is traded at $9.99, with a volume of 2.06M.
It is up +2.67% in the last 24 hours and up +3.20% over the past month.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
See More
Previous Close:
$9.73
Open:
$9.78
24h Volume:
2.06M
Relative Volume:
1.66
Market Cap:
$887.16M
Revenue:
$73.48M
Net Income/Loss:
$-108.30M
P/E Ratio:
-4.44
EPS:
-2.25
Net Cash Flow:
$-67.17M
1W Performance:
+33.56%
1M Performance:
+3.20%
6M Performance:
+109.00%
1Y Performance:
+187.90%
1-Day Range:
$9.65
$10.19
1-Week Range:
$7.11
$10.19
52-Week Range:
$2.8262
$10.95
Personalis Inc Stock (PSNL) Company Profile
Name
Personalis Inc
Sector
Industry
Phone
650-752-1300
Address
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
9.99 | 864.07M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-25 | Initiated | Guggenheim | Buy |
| Mar-17-25 | Initiated | Craig Hallum | Buy |
| Feb-06-23 | Upgrade | Needham | Hold → Buy |
| Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-03-21 | Downgrade | Needham | Buy → Hold |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-20-21 | Reiterated | Needham | Buy |
| May-06-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-28-21 | Initiated | Truist | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-12-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Aug-27-20 | Initiated | H.C. Wainwright | Buy |
| Aug-18-20 | Initiated | Needham | Buy |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Initiated | BofA/Merrill | Neutral |
| Jul-15-19 | Initiated | Cowen | Outperform |
| Jul-15-19 | Initiated | Morgan Stanley | Overweight |
| Jul-15-19 | Initiated | Oppenheimer | Outperform |
View All
Personalis Inc Stock (PSNL) Latest News
How Analyst Views Are Shifting as Personalis Transforms Its Growth Story - Yahoo Finance
Is Personalis Inc 04X a good long term investmentPrice-to-Earnings Ratio Insights & High Profit Market Growth - earlytimes.in
BTIG Maintains Personalis (PSNL) Buy Recommendation - MSN
Will Personalis Inc. stock recover faster than marketWeekly Profit Report & Fast Moving Market Watchlists - newser.com
Why retail investors favor Personalis Inc. stockJuly 2025 WrapUp & Fast Gain Swing Alerts - newser.com
Can Personalis Inc. stock resist market sell offsLong Setup & Free Technical Confirmation Trade Alerts - newser.com
Will Personalis Inc. (04X) stock benefit from Fed rate cuts2025 Market Sentiment & Daily Market Momentum Tracking - newser.com
Will Personalis Inc. (04X) stock beat Nasdaq index returnsJuly 2025 Macro Moves & Safe Entry Momentum Tips - newser.com
How Personalis Inc. (04X) stock trades after rate cuts2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Chart overlay techniques for tracking Personalis Inc.2025 Biggest Moves & Verified Entry Point Signals - newser.com
Can Personalis Inc. (04X) stock sustain double digit ROEAnalyst Downgrade & Daily Price Action Insights - newser.com
Is Personalis Inc. (04X) stock undervalued after correction2025 Performance Recap & Reliable Intraday Trade Plans - newser.com
Has Personalis Inc. found a price floorMarket Activity Recap & Risk Controlled Stock Pick Alerts - newser.com
Is Personalis Inc. stock ready for breakoutMarket Sentiment Review & Free Safe Capital Growth Stock Tips - newser.com
What technical signals suggest for Personalis Inc. stockOptions Play & Technical Pattern Alert System - newser.com
Relative strength of Personalis Inc. in sector analysis2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
Can Personalis Inc. (04X) stock sustain free cash flowWall Street Watch & Daily Oversold Bounce Ideas - newser.com
Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference - BioSpace
How robust is Personalis Inc. (04X) stock financial position - newser.com
Is Personalis Inc. stock trading at a premium valuation2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com
Personalis Inc Stock (PSNL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):